Digital Therapeutics Day 2021 – 30 November 2021
Digital Therapeutics Day 2021 #DTxDAY21 will be held on Nov 30, 2021.
For further information
Digital Therapeutics Day 2020 – 22 October 2020
daVinci Digital Therapeutics Web Conference 2020
The Youtube VideoPlaybook with the content of the Conference
Please wait while flipbook is loading. For more related info, FAQs and issues please refer to DearFlip WordPress Flipbook Plugin Help documentation.
Programme
10.00 | Welcome address | Giuseppe Recchia, Massimo Beccaria |
10.10 | Introduction to #DTxDay2020 | Emanuele Lettieri, Valerio Rosso |
SESSION 1 – Where are we now? | ||
10.20 | Digital Health : where are we now? | Emanuele Lettieri |
10.40 | Round Table Digital Therapeutics – Where are we now? Digital Therapeutics : where is Italy? Digital Therapeutics : where is Europe? Digital Therapeutics : where is the World? Discussion | Eugenio Santoro Gualberto Gussoni, Jessica Shull, Roberto Ascione |
12.00 | Decentralized Clinical Trials #DTC to develop #DTx : where are we now? | Massimo Beccaria |
12.20 | Reimbursement : where are we now? | Nello Martini |
12.40 | Discussion | Emanuele Lettieri, Valerio Rosso, Giuseppe Recchia, Massimo Beccaria |
13.00 | Break | |
SESSION 2 – Where are we going? | ||
14.00 | When will Digital Therapeutics enter into medical practice in our country? | Emanuele Lettieri, Valerio Rosso, Giuseppe Recchia, Massimo Beccaria |
14.10 | Round Table Digital Therapeutics, Drugs and Pharma : Replacement, Add-on, Combination. Where are we going? | Giuseppe Recchia Roberto Triola, Stefano Zagnoni, Federico Pantellini, Fabrizio Conicella Marco Gorini |
15.20 | Digital Therapeutics, Startup and Pharma : where are we going? | Bhima Mandolini, Filippo Modugno |
15.40 | Digital Therapeutics need Digital Excipients : where are we going? | Chiara Stanghini, Samantha Zanca, Daniela Garofalo, Gabriele Fassina |
16.00 | Serious Games as DTx Digital Active Ingredient : where are we going? | Lucia Pannese |
16.20 | From Deprexis to the next generation in Digital Therapeutics and Diagnostics | Elena Affortunati, Matthias Zenker |
16.40 | Discussion | Emanuele Lettieri, Valerio Rosso, Giuseppe Recchia, Massimo Beccaria |
17.30 | Closing Remarks | Emanuele Lettieri Valerio Rosso |
Faculty
- Elena Affortunati – GAIA AG, Hamburg – Germany
- Roberto Ascione – Healthware Group, Salerno – Italy
- Massimo Beccaria – daVinci Digital Therapeutics Srl, Milano – Italy
- Fabrizio Conicella – OpenZone SpA, Bresso (MI) – Italy
- Marco Gorini – AstraZeneca SpA, Basiglio (MI) – Italy
- Emanuele Lettieri – Politecnico, Milano – Italy
- Nello Martini – Fondazione RES, Roma – Italy
- Lucia Pannese – Imaginary srl, Milano – Italy
- Federico Pantellini – Roche, Monza (MB) – Italy
- Giuseppe Recchia – Fondazione Smith Kline, Verona – Italy
- Eugenio Santoro – Istituto Ricerche Farmacologiche Mario Negri IRCCS, Milano – Italy
- Jessica Shull – Digital Therapeutics Alliance Europe, Barcelona – Spain
- Valerio Rosso – Digital Psychiatry, Società Italiana Psichiatria – Italy
- Roberto Triola – Farmindustria, Roma – Italy
- Stefano Zagnoni – Janssen Cilag, Cologno Monzese (MB) – Italy
- Matthias Zenker – GAIA AG, Hamburg – Germany